The Scientist - Home

BOSTON—For the 20,000 members of the American Mathematical Society, this year’s centennial is an occasion for both celebration and concern. American mathematics in many ways is at its zenith in terms of prestige and scope. Yet federal support for the “pure” mathematics represented by the AMS has failed to keep up with inflation, and there is little hope for a turnabout until the federal deficit is brought under control. There is turmoil as well inside the AMS. After a

NEWS ANALYSIS WASHINGTON—Budget analysts refer to it as Account 302b. But scientists may want to use more colorful names once they realize it will almost certainly block the sizable R&D increases being proposed for 1989 by President Reagan. The budget process works well when spending is rising gradually each year,” observed John Hoimfeld, a staff member of the House Science, Space and Technology Committee who later this year will complete a multi-volume report on science policy fo

FRANKFURT—Environmental groups have managed to delay the construction here of a test plant to process genetically engineered human insulin. The argument over the facility, proposed by the giant chemical and pharmaceutical company Hoechst, has focused attention on the absence of binding legal regulations for biotechnology production facilities. Hoechst Chairman Wolfgang Hilger has called the latest setback “terrifying” and “ridiculous.” Last October Hoechst receiv

Changing times have depleted the ranks of physicians who enter into careers as researchers. The shortage of physician-scientists has prompted the National Institutes of Health, the Howard Hughes Medical Institute and similar organizations to offer fellowships and other incentives to entice graduated M.D.s into research careers. But these inducements may come too late in the education of a physician. Scientists often choose their careers because they were exposed at some point to a laboratory.

Ed Connors wants to send an SOS message to Congress: “Sorry, Out of Scientists.” That message makes Connors, a professor of mathematics at the University of Massachusetts at Amherst, the winner of THE SCIENTIST’s slogan contest (see November 2, 1987, p. 2). Readers were invited to submit “the best phrase to describe the pending shortage of scientific manpower in the United States” in five words or less. Connors tried but failed to get a local slogan competition

Analytical chemists trekking to New Orleans for this month’s Pittsburgh conference might be forgiven a certain amount of hubris. Their services are in demand, by industry and academia, as never before. “I think it’s the tightest area in chemistry, with the possible exception of polymer chemistry,” declares Ted Logan, Manager of Ph.D. recruiting at Procter & Gamble Co. Actually, the U.S. supply of Ph.D.s in analytical chemistry is rising. The compound growth rate of 6.7

WASHINGTON—A newly released study by the National Science Foundation reveals what many academic researchers know only too well: The quality and amount of instrumentation available in the physical and computer sciences and engineering are not keeping pace with their needs. A survey of of the largest U.S. research universities, conducted in 1985, revealed that 51 percent of the engineering chairs felt that present equipment within their departments prevents faculty from pursuing major rese

PALAISEAU, FRANCE—France takes great pride in its mathematical tradition. But its position has slipped since the days of Blaise Pascal, Pierre Fermat, Evariste Galois and the fictitious Bourbaki. Frenchman have collected five of 30 Fields medals awarded by the International Mathematicians' Congress since 1950, but only one has come in the past 20 years. And the number of mathematicians has declined precipitously since the 1970s, triggering a shortage that threatens the country’s p

NEW YORK—Biotechnology companies that had been on the verge of going public are adjusting to the post-Black Monday shortage of public capital without the major layoffs and cutbacks that some analysts had predicted. Because such companies tend to be small, with heavy research investments and few proven products, some analysts saw them as particularly vulnerable to takeovers and restructurings in their search for cash. But for at least two firms that scuttled their plans for initial publi

Here is a book that belongs on the desk of every biomedical researcher in the United States: Building a Healthy America Conquering Disease and Disability Facts, Figures and Funding, edited by Terry L. Lierman. Lierman is president of Capitol Associates, Inc., a Washington, D.C.-based government relations firm specializing in health-related issues and funding. The volume, published last November, is the successor to a series of handbooks initiated by Mary Lasker, all entitled Killers and Cripple

LONDON - The Thatcher government has decided to scrap existing schemes to help individual companies commercialize their research, in favor of support for a long-term collaborative effort between universities and industries throughout Europe. At the same time it is adding $35 million to the budget of the Department of Trade and Industry for innovative programs, and plans to continue its support for new high tech firms. "The government should not take on responsibilities which are primarily tho

The Soviet government has informed AAAS that the following scientists will speak on these topics: Y. VELIKHOV, vice president, USSR Academy of Sciences, A review of Soviet progress in science; K. FROLOV vice president, USSR Academy of Sciences, head, machine study section; no title. E. SOKOLOV head, general biology section, USSR Academy of Sciences, The rational uses of biological resources and their protection; Zh. ALFEROV, director, Joffe Physical Technical Institute, The development of semi